Skip to main content
Top
Published in: Inflammation 5/2018

01-10-2018 | ORIGINAL ARTICLE

Spilanthol Inhibits COX-2 and ICAM-1 Expression via Suppression of NF-κB and MAPK Signaling in Interleukin-1β-Stimulated Human Lung Epithelial Cells

Authors: Wen-Chung Huang, Ling-Yu Wu, Sindy Hu, Shu-Ju Wu

Published in: Inflammation | Issue 5/2018

Login to get access

Abstract

Spilanthol a phytochemical derived from the Spilanthes acmella plant has antimicrobial, antioxidant, and anti-inflammatory properties. This study evaluated its effects on the expression of intercellular adhesion molecule 1 (ICAM-1) and inflammation-related mediators in IL-1β-stimulated human lung epithelial A549 cells. Human lung epithelial A549 cells were pretreated with various concentrations of spilanthol (3–100 μM) followed by treatment with IL-1β to induce inflammation. The protein levels of pro-inflammatory cytokines, chemokines, and prostaglandin E2 (PGE2) were measured using ELISA. Cyclooxygenase-2 (COX-2), heme oxygenase (HO-1), nuclear transcription factor kappa-B (NF-κB), and mitogen-activated protein kinase (MAPK) were measured by immunoblotting. The mRNA expression levels of ICAM-1 and MUC5AC were determined by real-time polymerase chain reaction. Spilanthol decreased the expression of PGE2, COX-2, TNF-α, and MCP-1. It also decreased ICAM-1 expression and suppressed monocyte adhesion to IL-1β-stimulated A549 cells. Spilanthol also significantly inhibited the phosphorylation of MAPK and I-κB. These results suggest that spilanthol exerts anti-inflammatory effects by inhibiting the expression of the pro-inflammatory cytokines, COX-2, and ICAM-1 by inhibiting the NF-κB and MAPK signaling pathways.
Literature
1.
go back to reference Adcock, I.M., and P.J. Barnes. 2008. Molecular mechanisms of corticosteroid resistance. Chest 134 (2): 394–401.CrossRefPubMed Adcock, I.M., and P.J. Barnes. 2008. Molecular mechanisms of corticosteroid resistance. Chest 134 (2): 394–401.CrossRefPubMed
3.
go back to reference Whelan, R., C. Kim, M. Chen, J. Leiter, M.M. Grunstein, and H. Hakonarson. 2004. Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle. The European Respiratory Journal 24 (4): 559–567.CrossRefPubMed Whelan, R., C. Kim, M. Chen, J. Leiter, M.M. Grunstein, and H. Hakonarson. 2004. Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle. The European Respiratory Journal 24 (4): 559–567.CrossRefPubMed
4.
go back to reference Schwingshack, A., M. Duszyk, N. Brown, and R. Moqbe. 1999. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. The Journal of Allergy and Clinical Immunology 104 (5): 983–989.CrossRef Schwingshack, A., M. Duszyk, N. Brown, and R. Moqbe. 1999. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. The Journal of Allergy and Clinical Immunology 104 (5): 983–989.CrossRef
5.
go back to reference Wegner, C.D., R.H. Gunde, P. Reilly, N. Haynes, L.G. Letts, and R. Rothlein. 1990. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247 (26): 456–459.CrossRefPubMed Wegner, C.D., R.H. Gunde, P. Reilly, N. Haynes, L.G. Letts, and R. Rothlein. 1990. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247 (26): 456–459.CrossRefPubMed
6.
go back to reference Min, J.K., Y.M. Kim, S.W. Kim, M.C. Kwon, Y.Y. Kong, and I.K. Hwang. 2005. TNF-related activation-induced cytokine enhances leukocyte adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-B activation in endothelial cells. Journal of Immunology 175 (1): 531–540.CrossRef Min, J.K., Y.M. Kim, S.W. Kim, M.C. Kwon, Y.Y. Kong, and I.K. Hwang. 2005. TNF-related activation-induced cytokine enhances leukocyte adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-B activation in endothelial cells. Journal of Immunology 175 (1): 531–540.CrossRef
8.
go back to reference Fakler, C.R., B. Wu, H.W. McMicken, R.S. Geske, and S.E. Welty. 2000. Molecular mechanisms of lipopolysaccharide induced ICAM-1 expression in A549 cells. Inflammation Research 49 (2): 63–72.CrossRefPubMed Fakler, C.R., B. Wu, H.W. McMicken, R.S. Geske, and S.E. Welty. 2000. Molecular mechanisms of lipopolysaccharide induced ICAM-1 expression in A549 cells. Inflammation Research 49 (2): 63–72.CrossRefPubMed
9.
go back to reference Neil, S.H., C.C. Matthew, M.C. Lisa, J.B. Peter, and N. Robert. 2004. ICAM-1 expression is highly NF-•B-dependent in A549 cells No role for ERK and p38 MAPK. European Journal of Biochemistry 271 (4): 785–791.CrossRef Neil, S.H., C.C. Matthew, M.C. Lisa, J.B. Peter, and N. Robert. 2004. ICAM-1 expression is highly NF-•B-dependent in A549 cells No role for ERK and p38 MAPK. European Journal of Biochemistry 271 (4): 785–791.CrossRef
10.
go back to reference Pantano, C., J.L. Ather, J.F. Alcorn, M.E. Poynter, A.L. Brown, and A.S. Guala. 2008. Nuclear factor-kB activation in airway epithelium induces inflammation and hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine 177 (9): 959–969.CrossRefPubMedPubMedCentral Pantano, C., J.L. Ather, J.F. Alcorn, M.E. Poynter, A.L. Brown, and A.S. Guala. 2008. Nuclear factor-kB activation in airway epithelium induces inflammation and hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine 177 (9): 959–969.CrossRefPubMedPubMedCentral
11.
go back to reference Kato, A., and R.P. Schleimer. 2007. Beyond inflammation: Airway epithelial cells are at the interface of innate and adaptive immunity. Current Opinion in Immunology 19 (6): 711–720.CrossRefPubMedPubMedCentral Kato, A., and R.P. Schleimer. 2007. Beyond inflammation: Airway epithelial cells are at the interface of innate and adaptive immunity. Current Opinion in Immunology 19 (6): 711–720.CrossRefPubMedPubMedCentral
12.
go back to reference Jennifer, L.A., R.H. Samantha, M.W. Yvonne, H. Janssen, and E.P. Matthew. 2011. Airway epithelial NF-κB activation promotes allergic sensitization to an innocuous inhaled antigen. American Journal of Respiratory Cell and Molecular Biology 44 (5): 631–638.CrossRef Jennifer, L.A., R.H. Samantha, M.W. Yvonne, H. Janssen, and E.P. Matthew. 2011. Airway epithelial NF-κB activation promotes allergic sensitization to an innocuous inhaled antigen. American Journal of Respiratory Cell and Molecular Biology 44 (5): 631–638.CrossRef
13.
go back to reference Conti, P., and M. DiGioacchino. 2001. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy and Asthma Proceedings 22 (3): 133–137.CrossRefPubMed Conti, P., and M. DiGioacchino. 2001. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy and Asthma Proceedings 22 (3): 133–137.CrossRefPubMed
14.
go back to reference Min, T., D. Yunfei, and H.H. Tai. 2006. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells. Carcinogenesis 27 (11): 2170–2179.CrossRef Min, T., D. Yunfei, and H.H. Tai. 2006. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells. Carcinogenesis 27 (11): 2170–2179.CrossRef
15.
go back to reference Liu, W., Q. Liang, S. Balzar, S. Wenzel, M. Gorska, and R. Alam. 2008. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. The Journal of Allergy and Clinical Immunology 12 (4): 893–902.CrossRef Liu, W., Q. Liang, S. Balzar, S. Wenzel, M. Gorska, and R. Alam. 2008. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. The Journal of Allergy and Clinical Immunology 12 (4): 893–902.CrossRef
16.
go back to reference Wei, D., H.P.C. Jasmine, H.W. Chui, P.L. Bernard, and W. Fred. 2004. Anti-inflammatory effects of mitogen-activated protein kinase inhibitor U0126 in an asthma mouse model. Journal of Immunology 172 (11): 7053–7059.CrossRef Wei, D., H.P.C. Jasmine, H.W. Chui, P.L. Bernard, and W. Fred. 2004. Anti-inflammatory effects of mitogen-activated protein kinase inhibitor U0126 in an asthma mouse model. Journal of Immunology 172 (11): 7053–7059.CrossRef
17.
go back to reference Diasa, A.M.A., P. Santosa, I.J. Seabraa, R.N.C. Júniorc, M.E.M. Bragaa, and H.C. de Sousaa. 2012. Spilanthol from Spilanthes acmella flowers, leaves and stems obtained by selective supercritical carbon dioxide extraction. Journal of Supercritical Fluids 61: 62–70.CrossRef Diasa, A.M.A., P. Santosa, I.J. Seabraa, R.N.C. Júniorc, M.E.M. Bragaa, and H.C. de Sousaa. 2012. Spilanthol from Spilanthes acmella flowers, leaves and stems obtained by selective supercritical carbon dioxide extraction. Journal of Supercritical Fluids 61: 62–70.CrossRef
18.
go back to reference Wu, L.C., N.C. Fan, M.H. Lin, I.R. Chu, S.J. Huang, C.Y. Hu, and S.Y. Han. 2008. Anti-inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down regulating LPS-induced inflammatory mediators. Journal of Agricultural and Food Chemistry 56 (7): 2341–2349.CrossRefPubMed Wu, L.C., N.C. Fan, M.H. Lin, I.R. Chu, S.J. Huang, C.Y. Hu, and S.Y. Han. 2008. Anti-inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down regulating LPS-induced inflammatory mediators. Journal of Agricultural and Food Chemistry 56 (7): 2341–2349.CrossRefPubMed
19.
go back to reference Wu, S.J. 2015. Osthole attenuates inflammatory responses and regulates the expression of inflammatory mediators in HepG2 cells grown in differentiated medium from 3T3-L1 Preadipocytes. Journal of Medicinal Food 18 (9): 972–979.CrossRefPubMed Wu, S.J. 2015. Osthole attenuates inflammatory responses and regulates the expression of inflammatory mediators in HepG2 cells grown in differentiated medium from 3T3-L1 Preadipocytes. Journal of Medicinal Food 18 (9): 972–979.CrossRefPubMed
20.
go back to reference Yumi, Y., and B.G. Richard. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. The Journal of Clinical Investigation 107 (2): 35–42. Yumi, Y., and B.G. Richard. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. The Journal of Clinical Investigation 107 (2): 35–42.
21.
go back to reference Richter, E., K. Ventz, M. Harms, J. Mostertz, and F. Hochgräfe. 2016. Induction of macrophage function in human THP-1 cells is associated with rewiring of MAPK signaling and activation of MAP3K7 (TAK1) protein kinase. Frontiers in Cell and Development Biology. https://doi.org/10.3389/fcell.2016.00021. Richter, E., K. Ventz, M. Harms, J. Mostertz, and F. Hochgräfe. 2016. Induction of macrophage function in human THP-1 cells is associated with rewiring of MAPK signaling and activation of MAP3K7 (TAK1) protein kinase. Frontiers in Cell and Development Biology. https://​doi.​org/​10.​3389/​fcell.​2016.​00021.
22.
go back to reference Moldoveanu, B., P. Otmishi, P. Jani, J. Walker, X. Sarmiento, J. Guardiola, M. Saad, and Y. Jerry. 2009. Inflammatory mechanisms in the lung. Inflammation Research 2 (16): 1–11. Moldoveanu, B., P. Otmishi, P. Jani, J. Walker, X. Sarmiento, J. Guardiola, M. Saad, and Y. Jerry. 2009. Inflammatory mechanisms in the lung. Inflammation Research 2 (16): 1–11.
23.
go back to reference I-Ta, L. 2013. Chuen-Mao, Y. Inflammatory signalings involved in airway and pulmonary diseases. Mediat Inflamm. Article ID 791231,12 pages I-Ta, L. 2013. Chuen-Mao, Y. Inflammatory signalings involved in airway and pulmonary diseases. Mediat Inflamm. Article ID 791231,12 pages
24.
go back to reference Beck, S.B., C. Madjdpour, S. Kneller, U. Ziegler, T. Pasch, and R.P. Wuthrich. 2002. Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammation. The European Respiratory Journal 19 (6): 1142–1150.CrossRef Beck, S.B., C. Madjdpour, S. Kneller, U. Ziegler, T. Pasch, and R.P. Wuthrich. 2002. Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammation. The European Respiratory Journal 19 (6): 1142–1150.CrossRef
25.
go back to reference Suter, P.M., S. Suter, E. Girardin, P. Roux-Lombard, G.E. Grau, and J.M. Dayer. 1992. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. The American Review of Respiratory Disease 145 (5): 1016–1022.CrossRefPubMed Suter, P.M., S. Suter, E. Girardin, P. Roux-Lombard, G.E. Grau, and J.M. Dayer. 1992. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. The American Review of Respiratory Disease 145 (5): 1016–1022.CrossRefPubMed
26.
go back to reference Park, W.Y., R.B. Goodman, and K.P. Steinberg. 2001. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 164 (15): 1896–1903.CrossRefPubMed Park, W.Y., R.B. Goodman, and K.P. Steinberg. 2001. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 164 (15): 1896–1903.CrossRefPubMed
27.
go back to reference Prachayasittikul, V., S. Prachayasittikul, S. Ruchirawat, and V. Prachayasittikul. 2013. High therapeutic potential of Spilanthes Acmella, A Review. Excli J 12: 291–212.PubMedPubMedCentral Prachayasittikul, V., S. Prachayasittikul, S. Ruchirawat, and V. Prachayasittikul. 2013. High therapeutic potential of Spilanthes Acmella, A Review. Excli J 12: 291–212.PubMedPubMedCentral
28.
go back to reference Kevin, S., D. Delphine, M.C. Megan, M. Elisabeth, and G. Philippe. 2011. The traditional medicine Spilanthes acmella, and the alkylamides spilanthol and undeca-2E -ene -8,10-diynoic acid isobutylamide, demonstrate in vitro and in vivo anti-malarial activity. Phytotherapy Research 25 (7): 1098–1101.CrossRef Kevin, S., D. Delphine, M.C. Megan, M. Elisabeth, and G. Philippe. 2011. The traditional medicine Spilanthes acmella, and the alkylamides spilanthol and undeca-2E -ene -8,10-diynoic acid isobutylamide, demonstrate in vitro and in vivo anti-malarial activity. Phytotherapy Research 25 (7): 1098–1101.CrossRef
29.
go back to reference Ivones, H., M. Lucía, M. Ioanna, D. Rodrigo, D. Carla, P. Sylvia, M.T. Jorge, and G. Gabino. 2009. Anti-inflammatory effects of ethanolic extract and alkamides-derived from Heliopsis longipes roots. Journal of Ethnopharmacology 124 (3): 649–652.CrossRef Ivones, H., M. Lucía, M. Ioanna, D. Rodrigo, D. Carla, P. Sylvia, M.T. Jorge, and G. Gabino. 2009. Anti-inflammatory effects of ethanolic extract and alkamides-derived from Heliopsis longipes roots. Journal of Ethnopharmacology 124 (3): 649–652.CrossRef
30.
go back to reference Witkowska, A.M., and M.H. Borawska. 2004. Soluble intercellular adhesion molecule-1 (sICAM-1):an overview. European Cytokine Network 15 (2): 91–98.PubMed Witkowska, A.M., and M.H. Borawska. 2004. Soluble intercellular adhesion molecule-1 (sICAM-1):an overview. European Cytokine Network 15 (2): 91–98.PubMed
Metadata
Title
Spilanthol Inhibits COX-2 and ICAM-1 Expression via Suppression of NF-κB and MAPK Signaling in Interleukin-1β-Stimulated Human Lung Epithelial Cells
Authors
Wen-Chung Huang
Ling-Yu Wu
Sindy Hu
Shu-Ju Wu
Publication date
01-10-2018
Publisher
Springer US
Published in
Inflammation / Issue 5/2018
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0837-0

Other articles of this Issue 5/2018

Inflammation 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.